Member Info for The_Paladin

From Synairgen’s website, my quote for today:

“It Ain’t Over Till It’s Over…but It’s Never Over”

Dr. Anthony Fauci, New England Journal of Medicine, 26 November 2022

The advfn board is infested with trolls today. Best avoided at present. I would not believe a word of it. Made up disinformation to irritate and confuse investors - at best.

Nearly 2m shares have changed hands today. Considerably more than the low volumes seen in recent days and weeks. Something is going on? This isn’t what I had hoped for, but let us see what happens from here?

It is annoying, as there were excellent informative, and insightful comments in that thread. I reiterate my earlier request. Please ignore the trolls on this forum. They are ruining an otherwise meaningful discussion. Thankfully, one of them has departed to his comfort zone on another board.

My overall impression lies on the positive side in the sense that it continued to present Synairgen's case for investment to an informed audience. IMHO, the company should limit Dr. Monk's role to scientific presentations at high level conferences, as has been the case recently. Synairgen needs a more confident speaker with an engaging personality when participating in discussion groups. Conversations at this level require individuals who have both the personality ethic, as well as the work ethic. Dr Monk's commitment to Synairgen's conference presentation programme in recent months shows that he possesses the latter in abundance, but was out of his comfort zone yesterday. IMHO, Synairgen made a similar wrong choice in the P2 Home webinar, and should have profited from that experience.

I remain optimistic about Synairgen's future prospects although time is getting on, and it is important for the company to achieve a P3 equivalent trial invitation in the coming few months.

I am grateful for the recent comments from regular investors on this forum, which have added to my knowledge and understanding, as always. I would respectfully respect that the obvious trolls are ignored. They add nothing to the conversation.

GLA.

Here is the link for anyone who ho wishes to attend tomorrow’s presentation. Apologies if this has already been posted. (I haven’t been following the contributions as fully as before recently. This is due to the unfortunate low quality of some of the comments made on this board.)

Could viral infections one day be treated with the same ease as bacterial infections?

Join us, Scientific American, Dr. Charles Dela Cruz (Dela Cruz Charles), Rick B., PhD and Dr. Phillip Monk for a panel discussion on The Hunt for a Versatile Respiratory Virus Killer on Tuesday, December 6th at 10:30am EST / 3:30pm GMT in Washington D.C or virtually.

Register here: https://rb.gy/5phnkq

I believe so sparkyboy1. I shan’t be able to listen to it when it is broadcasted, but will catch up once it is made available online. ATB.

I wonder if there will be a release of an RNS to coincide with tomorrow’s Synairgen sponsored presentation? I have formed an impression that the company’s future lies in the USA?

“Could viral infections one day be treated with the same ease as bacterial infections? Join us, @sciam, @DelaCruzYaleMed, @RickABright & @PhillMonk for a panel discussion on 6 Dec, 10:30EST/15:30GMT in Washington D.C. or online.”

rb.gy/5phnkq

Like other investors on this forum, I am impressed that Dr. Rick Bright is participating. An endorsement from Dr. Bright would go a long way towards helping Synairgen to achieve its objectives.

https://www.rockefellerfoundation.org/profile/dr-rick-bright/

GLA.

What about Anguilla, and Aruba. These are islands located in the Caribbean Sea. Do they count?

With apologies. I didn't read the question properly. Not all my input either.

Algeria, Angola, Austria, Armenia, Antigua(and Barbuda), Andorra.

* I should have written Scientific American, and not National Geographical Society. Written at haste, hence the error.

Sponsoring a National Geographical Society conference on broad spectrum antiviral treatments, a podcast series on a similar theme, a twitter and LinkedIn presence, on top of a number of presentations on different but related themes at high-level conferences in recent months. Synairgen have analysed and presented a significant cache of significant data this year, and are pressing hard to get their message across. Credit is due to Brooke Clarke for the improvement in our Comms. It is only a matter of time before LTIs receive an RNS, which will significantly change our situation IMHO.

Doc.Daneeka. You are on good form today. I wish that there were more comments on this forum that made me smile :-) . Incidentally, I am not a literature expert and am reading the recently published 'An Accessible Iliad' by Emir Jackson. My wife's high-level book club, on the other hand are reading the more difficult Robert ***les translation, which is probably similar to the text that you are familiar with? When I saw the lyrical translation, I was interested in the narrative but needed to read it at a less demanding level. The Tolkien trilogy, on the other hand, was a personal choice. I shall no doubt bore the family over Christmas when the Peter Jackson DVDs finally emerge from their cellophane wrappers. ATB.

Thanks wpa5. Evidently, I should have looked in the Scientific American space. It would be helpful if it had been placed in the Synairgen space also, where uninformed investors are more likely to find it? Perhaps that will come about soon? Happy to see that they are pressing on with getting the message out. ATB.

Many thanks for posting that article Doc.Daneeka. Also for your response to my comment yesterday, which I enjoyed reading. I have since moved on to reading The Iliad. With something positive to look forward to next week, perhaps it may be onwards and upwards for Synairgen LTIs before I conclude with that particular saga? ATB.

Reference to next Tuesday's event has already been inserted on Synairgen's LinkedIn space. I cannot find any reference to it on twitter, or on Synairgen's website yet.

It is business as usual with sp**** early morning trading. The possible implications of the announcement has apparently had no discernible effect on the market thus far? This is not surprising, as we were well under the radar even when there was an impending announcement of the Sprinter top line data at the start of the year.

( Why did autocorrect change 'top line' to 'toppling' ? Quite ironic really.)

Thanks Brand. Surely, Synairgen wouldn't be sponsoring this event at that venue, unless they had something positive to announce? Have I read this incorrectly, or could this lead to the development that all LTIs have been waiting for? I shall be looking out for an RNS next Tuesday.

Latest on twitter

“ Trade show season is in full swing for @IQAI_IB! Packed days of meetings at this week's @RSNA conference with many follow-up meetings resulting from the recently held @SNO meeting.”

https://www.rsna.org/annual-meeting?gclid=EAIaIQobChMI2frJtZbR-wIVCtDtCh0a5QD8EAAYAyAAEgLDYvD_BwE

I haven’t seen the @IQAI_IB tag used previously. Is the company being rebranded?

Doc83. Totally agree. 100p is the minimum bid that would awaken my interest.